Ron Dewar
YOU?
Author Swipe
View article: Chemotherapy use in ovarian cancer patients diagnosed 2012–2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study
Chemotherapy use in ovarian cancer patients diagnosed 2012–2017 in Australia, Canada, Norway and the UK: An International Cancer Benchmarking Partnership (ICBP) population-based study Open
Even within the same age groups and stage strata, use of chemotherapy varied substantially between jurisdictions during the mid-2010s. Future work should examine use of surgery in combination with chemotherapy. The reasons for the internat…
View article: Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study
Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study Open
Background International variation in lung cancer survival may be partly explained by variation in stage-specific treatment use, but relevant comparative evidence is sparse. As part of the International Cancer Benchmarking Partnership, we …
View article: An international disease monitoring tool to estimate the likelihood of entry of animal health hazards from legal trade of live animals and products of animal origin imported from different countries (IDM+)
An international disease monitoring tool to estimate the likelihood of entry of animal health hazards from legal trade of live animals and products of animal origin imported from different countries (IDM+) Open
View article: Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019
Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019 Open
Background: Melanoma represents a significant public health challenge in Canada, contributing to the deaths of over 1000 individuals each year. Prince Edward Island and Nova Scotia were previously noted to have the highest incidence rates …
View article: Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study Open
International Cancer Benchmarking Partnership (funded by the Canadian Partnership Against Cancer, Cancer Council Victoria, Cancer Institute New South Wales, Cancer Research UK, Danish Cancer Society, National Cancer Registry Ireland, The C…
View article: Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study Open
International Cancer Benchmarking Partnership (funded by the Canadian Partnership Against Cancer, Cancer Council Victoria, Cancer Institute New South Wales, Cancer Research UK, Danish Cancer Society, National Cancer Registry Ireland, The C…
View article: Supplementary Figure 4 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 4 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for CML showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 8 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 8 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for melanoma showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Materials and Methods from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Materials and Methods from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary materials and methods outline SAS code used to fit flexible parametric survival model. Document includes a simple example along with a link to the Github repository containing full macro code and worked examples.
View article: Supplementary Figure 6 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 6 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for DLBCL showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Table 1 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Table 1 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary table containing sensitivity analysis results for females aged 55 at diagnosis.
View article: Data from Increase in the Life Expectancy of Patients with Cancer in the United States
Data from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Background:Cancer is becoming more of a chronic disease due to improvements in treatment and early detection for multiple cancer sites. To gain insight on increased life expectancy due to these improvements, we quantified trends in the los…
View article: Supplementary Figure 4 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 4 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for CML showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 7 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 7 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for lung cancer showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 1 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 1 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Illustration of loss in expectation of life for DLBCL for 55-year-old women diagnosed with DLBCL. The figure shows general population and cancer cohort survival curves and shows that the LEL is the difference in area underneath the two sur…
View article: Supplementary Figure 6 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 6 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for DLBCL showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 5 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 5 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for CRC showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Table 2 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Table 2 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary table containing sensitivity analysis results for males aged 55 at diagnosis.
View article: Supplementary Figure 5 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 5 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for CRC showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 7 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 7 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for lung cancer showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 3 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 3 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for breast cancer showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 2 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 2 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Proportion of loss in expectation of life by cancer site, shown over year at diagnosis by sex and age at diagnosis.
View article: Supplementary Table 3 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Table 3 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary table containing model fit criteria for final model for each cancer site.
View article: Supplementary Figure 2 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 2 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Proportion of loss in expectation of life by cancer site, shown over year at diagnosis by sex and age at diagnosis.
View article: Supplementary Table 2 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Table 2 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary table containing sensitivity analysis results for males aged 55 at diagnosis.
View article: Supplementary Table 1 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Table 1 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary table containing sensitivity analysis results for females aged 55 at diagnosis.
View article: Supplementary Figure 8 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 8 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for melanoma showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 3 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 3 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Timeline of treatment advances for breast cancer showing treatments that received FDA approval between 1975 and 2018.
View article: Supplementary Figure 1 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Figure 1 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Illustration of loss in expectation of life for DLBCL for 55-year-old women diagnosed with DLBCL. The figure shows general population and cancer cohort survival curves and shows that the LEL is the difference in area underneath the two sur…
View article: Supplementary Table 3 from Increase in the Life Expectancy of Patients with Cancer in the United States
Supplementary Table 3 from Increase in the Life Expectancy of Patients with Cancer in the United States Open
Supplementary table containing model fit criteria for final model for each cancer site.